Alwakeel J, Gader A M, Hurieb S, al-Momen A K, Mitwalli A, Abu Aisha H
Department of Medicine, King Khalid University Hospital, Riyadh, Saudi Arabia.
Int Urol Nephrol. 1996;28(2):255-61. doi: 10.1007/BF02550871.
Coagulation inhibitors and fibrinolytic parameters were studied in twelve patients on continuous ambulatory peritoneal dialysis (CAPD) and ten patients on haemodialysis (HD). Patients on CAPD exhibited higher levels of ATIII and proteins C and S than those on HD. No significant differences were noted in tPA and PAI levels. Both groups of patients showed higher levels of tPA than controls. Besides, patients on HD had significantly lower levels of ATIII and protein C than controls. PAI levels in both patient groups were similar to those of the controls, but tPA levels were higher in patients than in controls. These results indicate that HD is associated with marked diminution in the circulating levels of coagulation inhibitors. This is in contrast to CAPD patients who showed elevated levels of these inhibitors, despite their significant loss in the dialysate. The finding of enhanced fibrinolysis in both patient groups may be a natural protective mechanism against the development of a thrombotic tendency.
对12例持续非卧床腹膜透析(CAPD)患者和10例血液透析(HD)患者的凝血抑制剂和纤溶参数进行了研究。CAPD患者的抗凝血酶III(ATIII)、蛋白C和蛋白S水平高于HD患者。组织型纤溶酶原激活剂(tPA)和纤溶酶原激活物抑制剂(PAI)水平未发现显著差异。两组患者的tPA水平均高于对照组。此外,HD患者的ATIII和蛋白C水平显著低于对照组。两组患者的PAI水平与对照组相似,但患者的tPA水平高于对照组。这些结果表明,HD与循环中凝血抑制剂水平的显著降低有关。这与CAPD患者形成对比,尽管CAPD患者在透析液中有大量丢失,但这些抑制剂的水平却升高。两组患者纤溶增强的发现可能是一种防止血栓形成倾向发展的自然保护机制。